Author Claim Review

 Quick Explanation Copied

 Long Explanation

Evidence basis. The narrower profile ("E. Rohde": 2 papers, 0 citations) conflicts sharply with the OpenAlex-verified Eva Rohde profile (A5024617009, ORCID 0000-0001-8692-886X): 154 works, 29,042 citations, h-index 35, and citations rising monotonically to 4,527 in 2026 — a strongly still-active trajectory MISEV2018 citation metrics. Her two signature contributions are (1) a 2005 first-author Stem Cells paper showing blood monocytes can mimic endothelial progenitor cells, critically reframing EPC assays EPC mimicry by monocytes, first-author, and (2) co-developing human platelet lysate to replace fetal bovine serum for clinical-scale MSC expansion Platelet lysate MSC expansion. She has consistently shaped EV-therapy standardization (ISEV position papers, MSC-sEV definitions, manufacturing reviews) ISEV clinical EV position paper MSC-sEV definition consensus EV manufacturing review.

Limitations. Most top papers are consensus/position statements where Rohde is one of dozens of co-authors, so per-author contribution is unattributable; citation counts inflate via guideline adoption rather than independent empirical discovery. First-author empirical work is concentrated 2005–2010 in the Graz/Paracelsus groups. The 2-paper/h-0 profile is an entity-resolution artifact (French-language patent-style records), a known OpenAlex name-disambiguation blind spot — conclusions drawn from it alone would be misleading.

 BGPT Author Review

Scientific Quality

Strong translational record: first-author mechanistic paper (EPC mimicry), widely adopted MSC culture protocol, and co-authorship on field-standard ISEV guidelines. Docked points because most high-impact output is multi-author consensus work where individual contribution is hard to isolate, and no Nobel-tier or paradigm-creating single-author breakthroughs are evident.

Communication Quality

Co-authorship of MISEV guidelines and manufacturing reviews demonstrates ability to write clear, actionable standards adopted globally; some works are dense consensus documents, which is inherent to the genre.

Author Novelty

The 2005 monocyte/EPC mimicry paper was a genuinely critical corrective to a then-popular EPC narrative, and platelet-lysate MSC expansion was a practical innovation; later work is largely standardization and consolidation rather than new conceptual ground.

Scientific Rigor

Participation in MISEV rigor initiatives and careful falsification of EPC assay assumptions indicate methodological discipline; rigorous translational/GMP framing throughout. Some early EPC-era work was later substantially reinterpreted by the field, reflecting era-specific measurement limitations.